| Moclobemide: therapeutic use and clinical studies U Bonnet CNS drug reviews 9 (1), 97-140, 2003 | 317 | 2003 |
| How addictive are gabapentin and pregabalin? A systematic review U Bonnet, N Scherbaum European neuropsychopharmacology 27 (12), 1185-1215, 2017 | 270 | 2017 |
| The cannabis withdrawal syndrome: current insights U Bonnet, UW Preuss Substance abuse and rehabilitation, 9-37, 2017 | 231 | 2017 |
| Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study M Gastpar, U Bonnet, J Böning, K Mann, LG Schmidt, M Soyka, ... Journal of Clinical Psychopharmacology 22 (6), 592-598, 2002 | 159 | 2002 |
| Risks associated with the non-medicinal use of cannabis E Hoch, U Bonnet, R Thomasius, F Ganzer, U Havemann-Reinecke, ... Deutsches Ärzteblatt International 112 (16), 271, 2015 | 139 | 2015 |
| Treatment of alcohol withdrawal syndrome with gabapentin U Bonnet, M Banger, FM Leweke, M Maschke, T Kowalski, M Gastpar Pharmacopsychiatry 32 (03), 107-109, 1999 | 130 | 1999 |
| Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial U Bonnet, M Banger, FM Leweke, M Specka, BW Müller, T Hashemi, ... Journal of clinical psychopharmacology 23 (5), 514-519, 2003 | 119 | 2003 |
| Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons T Leniger, M Wiemann, D Bingmann, G Widman, A Hufnagel, U Bonnet Epilepsia 43 (5), 469-474, 2002 | 84 | 2002 |
| Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones U Bonnet, D Bingmann, M Wiemann European Neuropsychopharmacology 10 (2), 97-103, 2000 | 83 | 2000 |
| Modulation of voltage‐gated channel currents by harmaline and harmane F Splettstoesser, U Bonnet, M Wiemann, D Bingmann, D Büsselberg British Journal of Pharmacology 144 (1), 52-58, 2005 | 82 | 2005 |
| Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine’s antidepressant response and the development of ketamine addiction U Bonnet Journal of Psychoactive Drugs 47 (4), 276-285, 2015 | 80 | 2015 |
| Selective inhibition of the Na+/H+ exchanger type 3 activates CO2/H+-sensitive medullary neurones M Wiemann, JR Schwark, U Bonnet, HW Jansen, S Grinstein, RE Baker, ... Pflügers Archiv 438, 255-262, 1999 | 71 | 1999 |
| Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties U Bonnet CNS drug reviews 8 (3), 283-308, 2002 | 66 | 2002 |
| An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol U Bonnet, R Hamzavi-Abedi, M Specka, J Wiltfang, B Lieb, N Scherbaum Alcohol & Alcoholism 45 (2), 143-145, 2010 | 61 | 2010 |
| AWMF-Leitlinie: Cannabis-bezogene Störungen U Bonnet, K Harries-Hedder, FM Leweke, U Schneider, P Tossmann Fortschritte der Neurologie· Psychiatrie 72 (06), 318-329, 2004 | 57 | 2004 |
| Gabapentinoid benefit and risk stratification: mechanisms over myth H McAnally, U Bonnet, AD Kaye Pain and therapy 9 (2), 441-452, 2020 | 54 | 2020 |
| Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI M Maschke, J Weber, U Bonnet, A Dimitrova, J Bohrenkämper, S Sturm, ... Journal of neurology 252, 704-711, 2005 | 53 | 2005 |
| Alteration of intracellular pH and activity of CA3-pyramidal cells in guinea pig hippocampal slices by inhibition of transmembrane acid extrusion U Bonnet, T Leniger, M Wiemann Brain research 872 (1-2), 116-124, 2000 | 51 | 2000 |
| On the addictive power of gabapentinoids: a mini-review U Bonnet, EL Richter, K Isbruch, N Scherbaum Psychiatria Danubina 30 (2), 142-149, 2018 | 50 | 2018 |
| Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients M Specka, U Bonnet, M Heilmann, F Schifano, N Scherbaum Human Psychopharmacology: Clinical and Experimental 26 (6), 404-411, 2011 | 49 | 2011 |
